Nuvation Bio Inc.
NYSE:NUVB · New York Stock Exchange
+$0.06 today
Vol 3.71M · Avg 4.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+173.89%
Period High
$9.54
Period Low
$1.88
Latest
$5.56
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$3.84B
uniQure N.V.
NASDAQ:QURE
$2.94B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.61B
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.52B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.20B
Aurinia Pharmaceuticals Inc.
NASDAQ:AUPH
$2.09B
Ocular Therapeutix, Inc.
NASDAQ:OCUL
$2.07B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.66B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.49B
Janux Therapeutics, Inc.
NASDAQ:JANX
$851.04M
What is the latest NUVB filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does NUVB have?
Intrinsic Alpha currently shows 20 recent filings for NUVB.
Explore More
Continue the stock analysis
Jump to another research area for this company.